{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/BBIO/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-23T07:59:31.449Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":1707,"canonical_name":"BridgeBio Pharma, Inc.","cik":"0001743881","uei":null,"lei":null,"duns":null,"ticker":"BBIO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":86},"count":86,"timeline":[{"ts":"2026-07-22","kind":"sec.filing","form_type":"8-K","title":"8-K — BridgeBio Pharma, Inc. — 2026-07-22","url_slug":"/sec/cik-0001743881/8-k/0001140361-26-029291","accession_number":"0001140361-26-029291","importance":35},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — BridgeBio Pharma, Inc. — 2026-07-13","url_slug":"/sec/cik-0001743881/4/0001470831-26-000708","accession_number":"0001470831-26-000708","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — BridgeBio Pharma, Inc. — 2026-07-13","url_slug":"/sec/cik-0001743881/4/0001470831-26-000709","accession_number":"0001470831-26-000709","importance":30},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Cook Jennifer E.","title":null,"shares":112422,"price_per_share":90,"usd_value":10117980,"security_title":"Common Stock","importance":45.11798},{"ts":"2026-07-09","kind":"sec.form144","reporter":"JENNIFER COOK","title":"Director","shares":148589,"usd_value":13156008,"security_title":"Common","approx_sale_date":"2026-07-09","accession_number":"0001950047-26-006979","importance":42.6312016},{"ts":"2026-07-09","kind":"sec.form144","reporter":"ANDREA ELLIS","title":"Director","shares":17167,"usd_value":1442028,"security_title":"Common","approx_sale_date":"2026-07-09","accession_number":"0001950047-26-006976","importance":40.2884056},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Cook Jennifer E.","title":null,"shares":36167,"price_per_share":84,"usd_value":3038028,"security_title":"Common Stock","importance":38.038028},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Ellis Andrea","title":null,"shares":17167,"price_per_share":84,"usd_value":1442028,"security_title":"Common Stock","importance":36.442028},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Cook Jennifer E.","title":null,"shares":112422,"price_per_share":29,"usd_value":3260238,"security_title":"Common Stock","importance":18.260238},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Cook Jennifer E.","title":null,"shares":17167,"price_per_share":16.75,"usd_value":287547,"security_title":"Common Stock","importance":15.28754725},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Ellis Andrea","title":null,"shares":17167,"price_per_share":16.75,"usd_value":287547,"security_title":"Common Stock","importance":15.28754725},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Cook Jennifer E.","title":null,"shares":19000,"price_per_share":8.45,"usd_value":160550,"security_title":"Common Stock","importance":15.16055},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — BridgeBio Pharma, Inc. — 2026-07-02","url_slug":"/sec/cik-0001743881/8-k/0001140361-26-027445","accession_number":"0001140361-26-027445","importance":35},{"ts":"2026-06-26","kind":"sec.filing","form_type":"8-K","title":"8-K — BridgeBio Pharma, Inc. — 2026-06-26","url_slug":"/sec/cik-0001743881/8-k/0001140361-26-026506","accession_number":"0001140361-26-026506","importance":35},{"ts":"2026-06-24","kind":"sec.form144","reporter":"JENNIFER COOK","title":"Director","shares":37167,"usd_value":2601690,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001950047-26-006442","importance":40.520338},{"ts":"2026-06-24","kind":"sec.form144","reporter":"RANDAL SCOTT","title":"Director","shares":2196,"usd_value":150711,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001950047-26-006457","importance":40.030142296},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Cook Jennifer E.","title":null,"shares":37167,"price_per_share":70,"usd_value":2601690,"security_title":"Common Stock","importance":37.60169},{"ts":"2026-06-24","kind":"sec.filing","form_type":"144","title":"144 — BridgeBio Pharma, Inc. — 2026-06-24","url_slug":"/sec/cik-0001743881/144/0001950047-26-006442","accession_number":"0001950047-26-006442","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — BridgeBio Pharma, Inc. — 2026-06-24","url_slug":"/sec/cik-0001743881/4/0001470831-26-000630","accession_number":"0001470831-26-000630","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — BridgeBio Pharma, Inc. — 2026-06-24","url_slug":"/sec/cik-0001743881/4/0001470831-26-000635","accession_number":"0001470831-26-000635","importance":30},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Cook Jennifer E.","title":null,"shares":17167,"price_per_share":16.75,"usd_value":287547,"security_title":"Common Stock","importance":15.28754725},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Cook Jennifer E.","title":null,"shares":20000,"price_per_share":8.45,"usd_value":169000,"security_title":"Common Stock","importance":15.169},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Valantine Hannah","title":null,"shares":2196,"price_per_share":68.57,"usd_value":150580,"security_title":"Common Stock","importance":35.15057972},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Cook Jennifer E.","title":null,"shares":2196,"price_per_share":68.57,"usd_value":150580,"security_title":"Common Stock","importance":35.15057972},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — BridgeBio Pharma, Inc. — 2026-06-23","url_slug":"/sec/cik-0001743881/144/0001950047-26-006404","accession_number":"0001950047-26-006404","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — BridgeBio Pharma, Inc. — 2026-06-23","url_slug":"/sec/cik-0001743881/144/0001950047-26-006434","accession_number":"0001950047-26-006434","importance":30},{"ts":"2026-06-22","kind":"sec.form144","reporter":"HANNAH A VALANTINE","title":"Director","shares":2808,"usd_value":190944,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006349","importance":40.0381888},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Valantine Hannah","title":null,"shares":2808,"price_per_share":68,"usd_value":190944,"security_title":"Common Stock","importance":35.190944},{"ts":"2026-06-22","kind":"sec.filing","form_type":"144","title":"144 — BridgeBio Pharma, Inc. — 2026-06-22","url_slug":"/sec/cik-0001743881/144/0001950047-26-006349","accession_number":"0001950047-26-006349","importance":30},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Valantine Hannah","title":null,"shares":2808,"price_per_share":41.73,"usd_value":117178,"security_title":"Common Stock","importance":15.11717784},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Hassan Fred","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"HOMCY CHARLES J","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"DANIELS RONALD J","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"MOMTAZEE JAMES C","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"AGUIAR ERIC","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"MCCORMICK FRANK","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Satvat Ali J.","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Dachille Douglas A.","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Lo Andrew","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Ellis Andrea","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Valantine Hannah","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Cook Jennifer E.","title":null,"shares":3990,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.f","reporter":"HOMCY CHARLES J","title":null,"shares":788,"price_per_share":66.27,"usd_value":52221,"security_title":"Common Stock","importance":15.05222076},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — BridgeBio Pharma, Inc. — 2026-06-17","url_slug":"/sec/cik-0001743881/4/0001470831-26-000550","accession_number":"0001470831-26-000550","importance":30},{"ts":"2026-06-15","kind":"sec.form144","reporter":"JENNIFER COOK","title":"Director","shares":90240,"usd_value":6012159,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001950047-26-006155","importance":41.202431808},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Cook Jennifer E.","title":null,"shares":88737,"price_per_share":66.6153,"usd_value":5911242,"security_title":"Common Stock","importance":40.9112418761},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Cook Jennifer E.","title":null,"shares":1503,"price_per_share":67.1425,"usd_value":100915,"security_title":"Common Stock","importance":35.1009151775},{"ts":"2026-06-15","kind":"sec.filing","form_type":"144","title":"144 — BridgeBio Pharma, Inc. — 2026-06-15","url_slug":"/sec/cik-0001743881/144/0001950047-26-006155","accession_number":"0001950047-26-006155","importance":30},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Cook Jennifer E.","title":null,"shares":65921,"price_per_share":8.45,"usd_value":557032,"security_title":"Common Stock","importance":15.55703245},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Cook Jennifer E.","title":null,"shares":17167,"price_per_share":16.75,"usd_value":287547,"security_title":"Common Stock","importance":15.28754725},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":8437,"price_per_share":67.8848,"usd_value":572744,"security_title":"Common Stock","importance":35.5727440576},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":8437,"price_per_share":67.8848,"usd_value":572744,"security_title":"Common Stock","importance":35.5727440576},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":7148,"price_per_share":67.199,"usd_value":480338,"security_title":"Common Stock","importance":35.480338452},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":7147,"price_per_share":67.199,"usd_value":480271,"security_title":"Common Stock","importance":35.480271253},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":4416,"price_per_share":68.9593,"usd_value":304524,"security_title":"Common Stock","importance":35.3045242688},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":4415,"price_per_share":68.9593,"usd_value":304455,"security_title":"Common Stock","importance":35.3044553095},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":15921,"price_per_share":67.7378,"usd_value":1078454,"security_title":"Common Stock","importance":36.0784535138},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":15921,"price_per_share":67.7377,"usd_value":1078452,"security_title":"Common Stock","importance":36.0784519217},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":2200,"price_per_share":65.7202,"usd_value":144584,"security_title":"Common Stock","importance":35.14458444},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":2200,"price_per_share":65.7202,"usd_value":144584,"security_title":"Common Stock","importance":35.14458444},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":1429,"price_per_share":66.723,"usd_value":95347,"security_title":"Common Stock","importance":35.095347167},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":1429,"price_per_share":66.723,"usd_value":95347,"security_title":"Common Stock","importance":35.095347167},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":450,"price_per_share":68.2697,"usd_value":30721,"security_title":"Common Stock","importance":35.030721365},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":450,"price_per_share":68.2697,"usd_value":30721,"security_title":"Common Stock","importance":35.030721365},{"ts":"2026-05-21","kind":"sec.form144","reporter":"NEIL KUMAR","title":"Director, Officer","shares":26103,"usd_value":1780747,"security_title":"Common","approx_sale_date":"2026-05-21","accession_number":"0001950047-26-004909","importance":40.356149332},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — BridgeBio Pharma, Inc. — 2026-05-19","url_slug":"/sec/cik-0001743881/4/0001470831-26-000471","accession_number":"0001470831-26-000471","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — BridgeBio Pharma, Inc. — 2026-05-19","url_slug":"/sec/cik-0001743881/4/0001470831-26-000473","accession_number":"0001470831-26-000473","importance":30},{"ts":"2026-05-18","kind":"sec.form144","reporter":"THOMAS TRIMARCHI","title":"Officer","shares":13651,"usd_value":888419,"security_title":"Common","approx_sale_date":"2026-05-18","accession_number":"0001950047-26-004675","importance":40.177683874},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Trimarchi Thomas","title":"President and CFO","shares":10456,"price_per_share":64.8151,"usd_value":677707,"security_title":"Common Stock","importance":35.6777066856},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Trimarchi Thomas","title":"President and CFO","shares":3195,"price_per_share":65.9507,"usd_value":210712,"security_title":"Common Stock","importance":35.2107124865},{"ts":"2026-05-18","kind":"sec.filing","form_type":"144","title":"144 — BridgeBio Pharma, Inc. — 2026-05-18","url_slug":"/sec/cik-0001743881/144/0001950047-26-004675","accession_number":"0001950047-26-004675","importance":30},{"ts":"2026-05-16","kind":"sec.insider.f","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":36236,"price_per_share":66.13,"usd_value":2396287,"security_title":"Common Stock","importance":17.39628668},{"ts":"2026-05-16","kind":"sec.insider.f","reporter":"Trimarchi Thomas","title":"President and CFO","shares":22781,"price_per_share":66.13,"usd_value":1506508,"security_title":"Common Stock","importance":16.50650753},{"ts":"2026-05-16","kind":"sec.insider.f","reporter":"Apuli Maricel","title":"Chief Accounting Officer","shares":4714,"price_per_share":66.13,"usd_value":311737,"security_title":"Common Stock","importance":15.31173682},{"ts":"2026-05-16","kind":"sec.insider.m","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":33544,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-16","kind":"sec.insider.m","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":19599,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-16","kind":"sec.insider.m","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":11553,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-16","kind":"sec.insider.m","reporter":"Kumar Neil","title":"Chief Executive Officer","shares":6519,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Scott Randal W.","title":null,"shares":6200,"price_per_share":66.6878,"usd_value":413464,"security_title":"Common Stock","importance":35.41346436},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Scott Randal W.","title":null,"shares":2088,"price_per_share":67.5302,"usd_value":141003,"security_title":"Common Stock","importance":35.1410030576},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Scott Randal W.","title":null,"shares":1512,"price_per_share":68.2303,"usd_value":103164,"security_title":"Common Stock","importance":35.1031642136},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Scott Randal W.","title":null,"shares":200,"price_per_share":69.12,"usd_value":13824,"security_title":"Common Stock","importance":35.013824},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Scott Randal W.","title":null,"shares":10000,"price_per_share":16.75,"usd_value":167500,"security_title":"Common Stock","importance":15.1675},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — BridgeBio Pharma, Inc. — 2026-05-13","url_slug":"/sec/cik-0001743881/8-k/0001140361-26-021036","accession_number":"0001140361-26-021036","importance":35},{"ts":"2026-05-08","kind":"sec.filing","form_type":"8-K","title":"8-K — BridgeBio Pharma, Inc. — 2026-05-08","url_slug":"/sec/cik-0001743881/8-k/0001140361-26-019761","accession_number":"0001140361-26-019761","importance":35},{"ts":"2026-05-08","kind":"sec.filing","form_type":"S-3ASR","title":"S-3ASR — BridgeBio Pharma, Inc. — 2026-05-08","url_slug":"/sec/cik-0001743881/s-3asr/0001140361-26-019654","accession_number":"0001140361-26-019654","importance":30}]}